Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis

Bacterial vaginosis (BV) is typically caused by a shift in the vaginal microbiota from a Lactobacillus-dominant community to one colonised by strains of Gardenerella vaginalis and treatment with the antibiotic metronidazole (MNZ) often results in failure and recurrence. Here, the authors use modelli...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Christina Y. Lee, Ryan K. Cheu, Melissa M. Lemke, Andrew T. Gustin, Michael T. France, Benjamin Hampel, Andrea R. Thurman, Gustavo F. Doncel, Jacques Ravel, Nichole R. Klatt, Kelly B. Arnold
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/9d83bafea6184047b1ac4bc5543da3b9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9d83bafea6184047b1ac4bc5543da3b9
record_format dspace
spelling oai:doaj.org-article:9d83bafea6184047b1ac4bc5543da3b92021-12-02T14:41:02ZQuantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis10.1038/s41467-020-19880-w2041-1723https://doaj.org/article/9d83bafea6184047b1ac4bc5543da3b92020-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-19880-whttps://doaj.org/toc/2041-1723Bacterial vaginosis (BV) is typically caused by a shift in the vaginal microbiota from a Lactobacillus-dominant community to one colonised by strains of Gardenerella vaginalis and treatment with the antibiotic metronidazole (MNZ) often results in failure and recurrence. Here, the authors use modelling and in vitro assays to show that sequestration of MNZ by Lactobacillus is critical in reducing efficacy and women with a higher pre-treatment Lactobacillus/Gardnerella ratio are more likely to recur.Christina Y. LeeRyan K. CheuMelissa M. LemkeAndrew T. GustinMichael T. FranceBenjamin HampelAndrea R. ThurmanGustavo F. DoncelJacques RavelNichole R. KlattKelly B. ArnoldNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Christina Y. Lee
Ryan K. Cheu
Melissa M. Lemke
Andrew T. Gustin
Michael T. France
Benjamin Hampel
Andrea R. Thurman
Gustavo F. Doncel
Jacques Ravel
Nichole R. Klatt
Kelly B. Arnold
Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis
description Bacterial vaginosis (BV) is typically caused by a shift in the vaginal microbiota from a Lactobacillus-dominant community to one colonised by strains of Gardenerella vaginalis and treatment with the antibiotic metronidazole (MNZ) often results in failure and recurrence. Here, the authors use modelling and in vitro assays to show that sequestration of MNZ by Lactobacillus is critical in reducing efficacy and women with a higher pre-treatment Lactobacillus/Gardnerella ratio are more likely to recur.
format article
author Christina Y. Lee
Ryan K. Cheu
Melissa M. Lemke
Andrew T. Gustin
Michael T. France
Benjamin Hampel
Andrea R. Thurman
Gustavo F. Doncel
Jacques Ravel
Nichole R. Klatt
Kelly B. Arnold
author_facet Christina Y. Lee
Ryan K. Cheu
Melissa M. Lemke
Andrew T. Gustin
Michael T. France
Benjamin Hampel
Andrea R. Thurman
Gustavo F. Doncel
Jacques Ravel
Nichole R. Klatt
Kelly B. Arnold
author_sort Christina Y. Lee
title Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis
title_short Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis
title_full Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis
title_fullStr Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis
title_full_unstemmed Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis
title_sort quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/9d83bafea6184047b1ac4bc5543da3b9
work_keys_str_mv AT christinaylee quantitativemodelingpredictsmechanisticlinksbetweenpretreatmentmicrobiomecompositionandmetronidazoleefficacyinbacterialvaginosis
AT ryankcheu quantitativemodelingpredictsmechanisticlinksbetweenpretreatmentmicrobiomecompositionandmetronidazoleefficacyinbacterialvaginosis
AT melissamlemke quantitativemodelingpredictsmechanisticlinksbetweenpretreatmentmicrobiomecompositionandmetronidazoleefficacyinbacterialvaginosis
AT andrewtgustin quantitativemodelingpredictsmechanisticlinksbetweenpretreatmentmicrobiomecompositionandmetronidazoleefficacyinbacterialvaginosis
AT michaeltfrance quantitativemodelingpredictsmechanisticlinksbetweenpretreatmentmicrobiomecompositionandmetronidazoleefficacyinbacterialvaginosis
AT benjaminhampel quantitativemodelingpredictsmechanisticlinksbetweenpretreatmentmicrobiomecompositionandmetronidazoleefficacyinbacterialvaginosis
AT andrearthurman quantitativemodelingpredictsmechanisticlinksbetweenpretreatmentmicrobiomecompositionandmetronidazoleefficacyinbacterialvaginosis
AT gustavofdoncel quantitativemodelingpredictsmechanisticlinksbetweenpretreatmentmicrobiomecompositionandmetronidazoleefficacyinbacterialvaginosis
AT jacquesravel quantitativemodelingpredictsmechanisticlinksbetweenpretreatmentmicrobiomecompositionandmetronidazoleefficacyinbacterialvaginosis
AT nicholerklatt quantitativemodelingpredictsmechanisticlinksbetweenpretreatmentmicrobiomecompositionandmetronidazoleefficacyinbacterialvaginosis
AT kellybarnold quantitativemodelingpredictsmechanisticlinksbetweenpretreatmentmicrobiomecompositionandmetronidazoleefficacyinbacterialvaginosis
_version_ 1718390069799157760